Cargando…

Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation

Tumors reprogram their metabolic pathways to meet the bioenergetic and biosynthetic demands of cancer cells. These reprogrammed activities are now recognized as the hallmarks of cancer, which not only provide cancer cells with unrestricted proliferative and metastatic potentials, but also strengthen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bowen, Shi, Jianlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509697/
https://www.ncbi.nlm.nih.gov/pubmed/32999845
http://dx.doi.org/10.1002/advs.202001388
_version_ 1783585650072616960
author Yang, Bowen
Shi, Jianlin
author_facet Yang, Bowen
Shi, Jianlin
author_sort Yang, Bowen
collection PubMed
description Tumors reprogram their metabolic pathways to meet the bioenergetic and biosynthetic demands of cancer cells. These reprogrammed activities are now recognized as the hallmarks of cancer, which not only provide cancer cells with unrestricted proliferative and metastatic potentials, but also strengthen their resistance against stress conditions and therapeutic challenges. Although recent progress in nanomedicine has largely promoted the developments of various therapeutic modalities, such as photodynamic therapy, photothermal therapy, nanocatalytic therapy, tumor‐starving/suffocating therapy, etc., the therapeutic efficacies of nanomedicines are still not high enough to achieve satisfactory tumor‐suppressing effects. Therefore, researchers are obliged to look back to the essence of cancer cell biology, such as metabolism, for tailoring a proper therapeutic regimen. In this work, the characteristic metabolic pathways of cancer cells, such as aerobic respiration, glycolysis, autophagy, glutaminolysis, etc. are reviewed, to summarize the very recent advances in the smart design of nanomedicines that can regulate tumor metabolism for enhancing conventional therapeutic modalities. The underlying chemistry of these nanomedicines by which tumor metabolism is harnessed, is also discussed in a comprehensive manner. It is expected that by harnessing tumor metabolism cancer nanotherapeutics will be substantially improved in the future.
format Online
Article
Text
id pubmed-7509697
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75096972020-09-29 Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation Yang, Bowen Shi, Jianlin Adv Sci (Weinh) Reviews Tumors reprogram their metabolic pathways to meet the bioenergetic and biosynthetic demands of cancer cells. These reprogrammed activities are now recognized as the hallmarks of cancer, which not only provide cancer cells with unrestricted proliferative and metastatic potentials, but also strengthen their resistance against stress conditions and therapeutic challenges. Although recent progress in nanomedicine has largely promoted the developments of various therapeutic modalities, such as photodynamic therapy, photothermal therapy, nanocatalytic therapy, tumor‐starving/suffocating therapy, etc., the therapeutic efficacies of nanomedicines are still not high enough to achieve satisfactory tumor‐suppressing effects. Therefore, researchers are obliged to look back to the essence of cancer cell biology, such as metabolism, for tailoring a proper therapeutic regimen. In this work, the characteristic metabolic pathways of cancer cells, such as aerobic respiration, glycolysis, autophagy, glutaminolysis, etc. are reviewed, to summarize the very recent advances in the smart design of nanomedicines that can regulate tumor metabolism for enhancing conventional therapeutic modalities. The underlying chemistry of these nanomedicines by which tumor metabolism is harnessed, is also discussed in a comprehensive manner. It is expected that by harnessing tumor metabolism cancer nanotherapeutics will be substantially improved in the future. John Wiley and Sons Inc. 2020-08-07 /pmc/articles/PMC7509697/ /pubmed/32999845 http://dx.doi.org/10.1002/advs.202001388 Text en © 2020 The Authors. Published by Wiley‐VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Yang, Bowen
Shi, Jianlin
Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
title Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
title_full Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
title_fullStr Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
title_full_unstemmed Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
title_short Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation
title_sort chemistry of advanced nanomedicines in cancer cell metabolism regulation
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509697/
https://www.ncbi.nlm.nih.gov/pubmed/32999845
http://dx.doi.org/10.1002/advs.202001388
work_keys_str_mv AT yangbowen chemistryofadvancednanomedicinesincancercellmetabolismregulation
AT shijianlin chemistryofadvancednanomedicinesincancercellmetabolismregulation